Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2017. The Company also...
Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer and global leader for over thirty years, announced the launch of its FDA-Cleared...
Psychemedics Corporation (NASDAQ: PMD), hair testing pioneer and global scientific leader for over thirty years, announced the launch of its...
Psychemedics Corporation (NASDAQ: PMD) today announced it has become the first laboratory to be approved for the testing of drugs of abuse in hair by ...
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2017. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2017. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2016. The...
Psychemedics Corporation (NASDAQ: PMD) today announced that recent volatility in its stock price on January 31, 2017 appears to have been caused by a ...
Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2016. The Company also...
Psychemedics Corporation (NASDAQ: PMD), the world's leading and largest hair analysis drug testing company, announced that it has been certified as a ...
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2016. The Company also...
Psychemedics Corporation (NASDAQ: PMD) announced that James P. Abely has joined the company as Associate General Counsel. In this important role, Jim ...
Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2016. The Company also...
Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2015. The...
Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2015. The Company also...
Psychemedics Corporation's (PMD: NASDAQ) Board of Directors has voted to expand the Board to five members from the current four members. At the same...
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2015. The Company also...
Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to...
Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2015. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2014. The...
Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2014. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2014. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2014. The Company also...
Psychemedics Corporation (NASDAQ: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2013. The...
Psychemedics Corporation (NASDAQ:PMD) today noted that the Brazilian Federal Government has announced new guidelines that will require professional...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.